The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2022

Filed:

Sep. 13, 2019
Applicants:

The Secretary of State for Defence, Salisbury, GB;

The University of Strathclyde, Glasgow, GB;

Inventors:

Ethel Diane Williamson, Salisbury, GB;

Riccardo Vincenzo D'Elia, Salisbury, GB;

Craig William Roberts, Glasgow, GB;

Stuart Woods, Glasgow, GB;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/69 (2017.01); A61K 47/54 (2017.01); A61P 31/14 (2006.01); A61P 31/04 (2006.01); A61K 9/127 (2006.01); A61K 31/496 (2006.01); A61K 31/513 (2006.01); A61K 31/5383 (2006.01); A61K 31/65 (2006.01); A61K 31/711 (2006.01); A61K 38/21 (2006.01); A61K 47/14 (2017.01); A61K 47/24 (2006.01); A61K 47/26 (2006.01); A61K 47/28 (2006.01); A61K 47/42 (2017.01); C07K 16/10 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6911 (2017.08); A61K 9/1272 (2013.01); A61K 9/1277 (2013.01); A61K 31/496 (2013.01); A61K 31/513 (2013.01); A61K 31/5383 (2013.01); A61K 31/65 (2013.01); A61K 31/711 (2013.01); A61K 38/212 (2013.01); A61K 38/217 (2013.01); A61K 47/14 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/28 (2013.01); A61K 47/42 (2013.01); A61K 47/545 (2017.08); A61P 31/04 (2018.01); A61P 31/14 (2018.01); C07K 16/1081 (2013.01);
Abstract

The invention relates to methods for the preparation of a pharmaceutical-vesicle formulation comprising steps of: preparing and processing vesicle components and a pharmaceutical agent to entrap the pharmaceutical agent in the vesicle and form a pharmaceutical-vesicle formulation, wherein the pharmaceutical-vesicle formulation is reconstituted in a known quantity of the pharmaceutical agent dissolved in a pharmaceutically-acceptable carrier to provide a biphasic pharmaceutical-vesicle formulation. The invention also relates to the associated pharmaceutical-vesicle formulations, pharmaceutical kits and uses as a medicament, in particular for the prevention or treatment of infection by bacteria such asand, and viruses such as Venezuelan Equine Encephalitis Virus (VEEV).


Find Patent Forward Citations

Loading…